Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Langley

Showing results (111-120 of 333) with videos related to

Pageof 34
Sort By:
Life Sciences|August 26, 1998
Impaired growth and increased glucocorticoid-sensitive enzyme activities in tissues of rat fetuses exposed to maternal low protein dietsS C Langley-Evans, M Nwagwu
Hypertension (Dallas, Tex. : 1979)|July 29, 2005
Essential hypertension: defending the contribution of a congenital nephron deficitSarah McMullen, Simon C Langley-Evans
Hypertension (Dallas, Tex. : 1979)|October 19, 2005
Sex-specific effects of prenatal low-protein and carbenoxolone exposure on renal angiotensin receptor expression in ratsSarah McMullen, Simon C Langley-Evans
Nursing in Critical Care|February 1, 2019
Critically ill patients' experiences of nursing care in the intensive care unitLeah C Kisorio, Gayle C Langley
Intensive & Critical Care Nursing|January 22, 2016
Intensive care nurses' experiences of end-of-life careLeah C Kisorio, Gayle C Langley
Clinical Therapeutics|July 1, 1997
Treatment costs, equilibrium, and the allocation of patients to therapy alternativesP C Langley, S K Bhattacharyya
Cell Motility and the Cytoskeleton|January 1, 1987
Cell type-specific association between two types of spectrin and two types of intermediate filamentsR C Langley, C M Cohen
Innovations in Pharmacy|November 30, 2023
After The QALY: Training for a New Start Paradigm in Health Technology AssessmentPaul C Langley, Elliott M Sogol
Innovations in Pharmacy|May 19, 2021
If You Build it Will They Come? Patients, Providers and Blockchains in Health Technology AssessmentPaul C Langley, Robert E Martin
Innovations in Pharmacy|May 19, 2021
Blockchains, Property Rights and Health Technology Assessment in the Pharmaceutical and Device (s) IndustriesPaul C Langley, Robert E Martin
Pageof 34

Showing results (111-120 of 333) with videos related to

Sort By:
Pageof 34
Life Sciences|August 26, 1998
Impaired growth and increased glucocorticoid-sensitive enzyme activities in tissues of rat fetuses exposed to maternal low protein dietsS C Langley-Evans, M Nwagwu
Hypertension (Dallas, Tex. : 1979)|July 29, 2005
Essential hypertension: defending the contribution of a congenital nephron deficitSarah McMullen, Simon C Langley-Evans
Hypertension (Dallas, Tex. : 1979)|October 19, 2005
Sex-specific effects of prenatal low-protein and carbenoxolone exposure on renal angiotensin receptor expression in ratsSarah McMullen, Simon C Langley-Evans
Nursing in Critical Care|February 1, 2019
Critically ill patients' experiences of nursing care in the intensive care unitLeah C Kisorio, Gayle C Langley
Intensive & Critical Care Nursing|January 22, 2016
Intensive care nurses' experiences of end-of-life careLeah C Kisorio, Gayle C Langley
Clinical Therapeutics|July 1, 1997
Treatment costs, equilibrium, and the allocation of patients to therapy alternativesP C Langley, S K Bhattacharyya
Cell Motility and the Cytoskeleton|January 1, 1987
Cell type-specific association between two types of spectrin and two types of intermediate filamentsR C Langley, C M Cohen
Innovations in Pharmacy|November 30, 2023
After The QALY: Training for a New Start Paradigm in Health Technology AssessmentPaul C Langley, Elliott M Sogol
Innovations in Pharmacy|May 19, 2021
If You Build it Will They Come? Patients, Providers and Blockchains in Health Technology AssessmentPaul C Langley, Robert E Martin
Innovations in Pharmacy|May 19, 2021
Blockchains, Property Rights and Health Technology Assessment in the Pharmaceutical and Device (s) IndustriesPaul C Langley, Robert E Martin
Pageof 34